Avalon Globocare Corp is a commercial-stage company dedicated to developing and delivering innovative, transformative, precision diagnostics and clinical laboratory services..
Avalon GloboCare News
Company to begin trading tomorrow under new Nasdaq ticker symbol CHGA as it advances its portfolio of agentic AI software platforms, including Beacon and Catch-...
Avalon GloboCare Corp. (NASDAQ:ALBT) said Monday it is rebranding as Change Agents Corp. as it completes its transition into a pure-play agentic artificial inte...
Subscription-based software platform expected to launch in late Q3 2026, expanding Avalon’s recurring SaaS portfolio alongside its Catch-Up agentic video stud...
Avalon Provides Update on POOL/PACT InitiativeFREEHOLD, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASD...
Company Continues to Execute Growth Strategy Focused on Next-Generation Agentic AI SystemsFREEHOLD, N.J., June 04, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Cor...
AWS collaboration accelerates Catch-Up Phase 2 development to a fully autonomous Agentic AI Video PlatformFREEHOLD, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Ava...
Collaboration Strengthens Development Roadmap and Supports Scalable Growth and MonetizationFREEHOLD, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare C...
$3.25 Million Upfront With up to Approximately $6.5 Million of Potential Aggregate Proceeds Upon the Exercise in Full of WarrantsFREEHOLD, N.J., Feb. 27, 2026 (...
Avalon GloboCare (ALBT) announced that it has been accepted into the Advanced Micro Devices (AMD) AI Developer Program, providing the Company with access to AMD...
Disclaimer: